// App-Quantinova.ai

OP0094 : COST-EFFECTIVENESS OF BIOLOGIC VERSUS CONVENTIONAL COMBINATION TREATMENT IN EARLY RHEUMATOID ARTHRITIS: 2-YEAR RESULTS OF THE RANDOMISED CONTROLLED SWEFOT TRIAL

Researchers

Presenter

  • J. Eriksson

Principal Investigators

  • J. A. Karlsson

  • J. Bratt

  • I. F. Petersson

  • R. F. van Vollenhoven

  • S. Ernestam

  • P. Geborek

  • M. Neovius

Medical Centers

  • Lund University Hospital, Lund, Sweden

Locations

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Methotrexate

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved